216 related articles for article (PubMed ID: 238851)
1. Effects of aldrin-transdiol on neuromuscular facilitation and depression.
Akkermans LM; van den Bercken J; van der Zalm J
Eur J Pharmacol; 1975 Apr; 31(2):166-75. PubMed ID: 238851
[TBL] [Abstract][Full Text] [Related]
2. Changes of quantal transmitter release caused by gadolinium ions at the frog neuromuscular junction.
Molgó J; del Pozo E; Baños JE; Angaut-Petit D
Br J Pharmacol; 1991 Sep; 104(1):133-8. PubMed ID: 1686201
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the action of 4-aminopyridine during repetitive stimulation at the neuromuscular junction.
Molgó J; Lemeignan M; Lechat P
Eur J Pharmacol; 1979 Jan; 53(3):307-11. PubMed ID: 32061
[TBL] [Abstract][Full Text] [Related]
4. Excitatory and depressant effects of dieldrin and aldrin-transdiol in the spinal cord of the toad (Xenopus laevis).
Akkermans LM; Van den Bercken J; Versluijs-Helder M
Eur J Pharmacol; 1975 Nov; 34(1):133-42. PubMed ID: 1234759
[TBL] [Abstract][Full Text] [Related]
5. The effect of (+)-tubocurarine on neuromuscular transmission during repetitive stimulation in the rat, mouse, and frog.
Magleby KL; Pallotta BS; Terrar DA
J Physiol; 1981 Mar; 312():97-113. PubMed ID: 6267269
[TBL] [Abstract][Full Text] [Related]
6. Effects of 4-aminopyridine at the frog neuromuscular junction.
Molgo J; Lemeignan M; Lechat P
J Pharmacol Exp Ther; 1977 Dec; 203(3):653-63. PubMed ID: 21957
[TBL] [Abstract][Full Text] [Related]
7. Modification by lithium of transmitter release at the neuromuscular junction of the frog.
Branisteanu DD; Volle RL
J Pharmacol Exp Ther; 1975 Aug; 194(2):362-72. PubMed ID: 239225
[TBL] [Abstract][Full Text] [Related]
8. [Changes in transmitter release at frog neuromuscular junction induced by 4-aminopyridine].
Molgo J; Lemeignan M; Lechat P
C R Acad Hebd Seances Acad Sci D; 1975 Nov; 281(21):1637-9. PubMed ID: 3292
[TBL] [Abstract][Full Text] [Related]
9. Prolonged nerve stimulation causes changes in transmitter release at the frog neuromuscular junction.
Hinz I; Wernig A
J Physiol; 1988 Jul; 401():557-65. PubMed ID: 2902219
[TBL] [Abstract][Full Text] [Related]
10. Effects of botulinum toxin on neuromuscular transmission in the rat.
Cull-Candy SG; Lundh H; Thesleff S
J Physiol; 1976 Aug; 260(1):177-203. PubMed ID: 184273
[TBL] [Abstract][Full Text] [Related]
11. The relation between quantum content and facilitation at the neuromuscular junction of the frog.
Mallart A; Martin AR
J Physiol; 1968 Jun; 196(3):593-604. PubMed ID: 4298821
[TBL] [Abstract][Full Text] [Related]
12. Observations on the action of type A botulinum toxin on frog neuromuscular junctions.
Boroff DA; del Castillo J; Evoy WH; Steinhardt RA
J Physiol; 1974 Jul; 240(2):227-53. PubMed ID: 4371582
[TBL] [Abstract][Full Text] [Related]
13. Facilitation, augmentation and potentiation of transmitter release at frog neuromuscular junctions poisoned with botulinum toxin.
Lupa MT; Tabti N
Pflugers Arch; 1986 Jun; 406(6):636-40. PubMed ID: 2872654
[TBL] [Abstract][Full Text] [Related]
14. Increase in transmitter release from motor nerve terminals induced by some pyridine derivatives.
Montoya GA; Molgó J; Lemeignan M; Lechat P
Acta Physiol Pharmacol Latinoam; 1984; 34(4):409-18. PubMed ID: 6242265
[TBL] [Abstract][Full Text] [Related]
15. Temperature-sensitive aspects of evoked and spontaneous transmitter release at the frog neuromuscular junction.
Barrett EF; Barrett JN; Botz D; Chang DB; Mahaffey D
J Physiol; 1978 Jun; 279():253-73. PubMed ID: 209175
[TBL] [Abstract][Full Text] [Related]
16. Effects of tubocurarine on end-plate current rundown and quantal content during rapid nerve stimulation in the snake.
Harborne AJ; Bowman WC; Marshall IG
Clin Exp Pharmacol Physiol; 1988 Jun; 15(6):479-90. PubMed ID: 3271621
[TBL] [Abstract][Full Text] [Related]
17. Studies on the mode of action of botulinum toxin type A at the frog neuromuscular junction.
Molgó J; Thesleff S
Brain Res; 1984 Apr; 297(2):309-16. PubMed ID: 6326941
[TBL] [Abstract][Full Text] [Related]
18. Presynaptic effects of bekanamycin at the frog neuromuscular junction. Reversibility by calcium and aminopyridines.
Uchiyama T; Molgo J; Lemeignan M
Eur J Pharmacol; 1981 Jul; 72(4):271-80. PubMed ID: 6268416
[TBL] [Abstract][Full Text] [Related]
19. Run-down of neuromuscular transmission during repetitive nerve activity by nicotinic antagonists is not due to desensitization of the postsynaptic receptor.
Hong SJ; Chang CC
Br J Pharmacol; 1991 Apr; 102(4):817-22. PubMed ID: 1677297
[TBL] [Abstract][Full Text] [Related]
20. Effects of 4-aminopyridine and 3,4-diaminopyridine on transmitter release at the neuromuscular junction.
Thomsen RH; Wilson DF
J Pharmacol Exp Ther; 1983 Oct; 227(1):260-5. PubMed ID: 6137556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
